sulfinpyrazone has been researched along with Libman-Sacks Disease in 2 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clark, WF | 1 |
| Tevaarwerk, GJ | 1 |
| Moriarity, TA | 1 |
| Reid, BD | 1 |
| Join, F | 1 |
| Tremblay, F | 1 |
2 other studies available for sulfinpyrazone and Libman-Sacks Disease
| Article | Year |
|---|---|
Inhibitors of immune complex induced human platelet aggregation and release in plasma.
Topics: Antibodies; Antigen-Antibody Complex; Aspirin; Blood Platelets; Depression, Chemical; Dipyridamole; | 1982 |
Platelet reactions and immune processes. II. The inhibition of platelet aggregation by complement inhibitors.
Topics: Aldehydes; Blood Platelets; Catechols; Cell Membrane; Chloroquine; Colchicine; Collagen; Complement | 1969 |